Is Sun Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sun Pharmaceutical pays dividends. Last time was Friday 16th of August 2024 where the investors holding the stock on Friday 12th of July 2024 were paid INR5 per share. Over the last 35 times between 1996 and 2024, Sun Pharmaceutical has paid INR172.75 with an average of INR4.94 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sun Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR428.80, you would have made a profit of INR1 395.75 per share or 325.50%
Yes, the average daily trading liquidity for Sun Pharmaceutical is INR2.17 million. You should therefore be able to get in and out of your positions relatively fast.
Sun Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.28, the company's ability to pay off the debt is good. Sun Pharmaceutical has a good net profit margin of 19.98% and should have high tolerances against inflation.
We have calculated the inflation risk for Sun Pharmaceutical to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.